Allan Frank Fischer Petersen

Direttore/Membro del Consiglio presso Biogen (Denmark) A/S

Health Technology

Profilo

Allan Frank Fischer Petersen is currently a Director at Biogen (Denmark).
A since 2012.
He previously worked as the Chief Executive Officer at FUJIFILM Diosynth Biotechnologies Holdings Denmark ApS.

Posizioni attive di Allan Frank Fischer Petersen

Società	Posizione	Inizio
Biogen (Denmark) A/S Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark.	Direttore/Membro del Consiglio	10/04/2012

Tutte le posizioni attive di Allan Frank Fischer Petersen

Precedenti posizioni note di Allan Frank Fischer Petersen

Società	Posizione	Fine
Biogen (Denmark) New Manufacturing ApS Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark.	Amministratore Delegato	-

Vedi nel dettaglio l'esperienza di Allan Frank Fischer Petersen

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Allan Frank Fischer Petersen

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Biogen (Denmark) A/S Biogen (Denmark) A/S BiotechnologyHealth Technology Biogen (Denmark) A/S manufactures therapies and pharmaceuticals. The company is headquartered in Glostrup, Denmark.	Health Technology
Biogen (Denmark) New Manufacturing ApS Biogen (Denmark) New Manufacturing ApS BiotechnologyHealth Technology Biogen (Denmark) New Manufacturing ApS engages in neuroscience. The firm offers therapies for multiple sclerosis, Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis, as well as less common diseases such as spinal muscle atrophy, and progressive supranuclear palsy. The company was founded on July 1, 2008 and is headquartered in Hillerod, Denmark.	Health Technology